Empagliflozin Protects HK-2 Cells from High Glucose-Mediated Injuries via a Mitochondrial Mechanism

Empagliflozin is known to retard the progression of kidney disease in diabetic patients. However, the underlying mechanism is incompletely understood. High glucose induces oxidative stress in renal tubules, eventually leading to mitochondrial damage. Here, we investigated whether empagliflozin exhib...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Wen-Chin, Chau, You-Ying, Ng, Hwee-Yeong, Chen, Chiu-Hua, Wang, Pei-Wen, Liou, Chia-Wei, Lin, Tsu-Kung, Chen, Jin-Bor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6770192/
https://www.ncbi.nlm.nih.gov/pubmed/31540085
http://dx.doi.org/10.3390/cells8091085

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6770192/
https://www.ncbi.nlm.nih.gov/pubmed/31540085
http://dx.doi.org/10.3390/cells8091085

Ejemplares similares